Professor of Medicine, University Tex SW Dallas
Cardiology
Dr. Mark H. Drazner, MD
|
|
Give Review
Mark Drazner is an expert in the field of Cardiology. He studied medicine at Washington University School of Medicine in St. Louis. He over the years received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Super Doctor". Mark Drazner is a published MD as well. He has 99 publications published. The latest was: Association Between Bendopnea and Key Parameters of Cardiopulmonary Exercise Testing in Patients With Advanced Heart Failure. Mark H. Drazner accepts Medicare.
Publications
- Association Between Bendopnea and Key Parameters of Cardiopulmonary Exercise Testing in Patients With Advanced Heart Failure.
- Restoration of Pulsatile Flow Reduces Sympathetic Nerve Activity Among Individuals With Continuous-Flow Left Ventricular Assist Devices.
- Changes in mid-life fitness predicts Heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Lo...
- Exercise Training in Patients with Heart Failure and Preserved Ejection Fraction: A Meta-analysis of Randomized Control Trials.
- In-Hospital CardioPulmonary Arrests in Patients with Left Ventricular Assist Devices.
- Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices.
- Factors Influencing the Rate of Flow Through Continuous-Flow Left Ventricular Assist Devices at Rest and With Exercise.
- Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the cooper center longitudinal study.
- A Sensitive Cardiac Troponin I Assay to Screen for Acute Rejection in Heart Transplant Patients.
- Characterization of a novel symptom of advanced Heart failure: bendopnea.
- Impact of Vice President Cheney on Public Interest in Left Ventricular Assist Devices and Heart Transplantation.
- Do established biomarkers such as B-type natriuretic peptide and troponin predict rejection?
- Relation of Regional Fat Distribution to Left Ventricular Structure and Function.
- Allocating scarce resources in real-time to reduce Heart failure readmissions: a prospective, controlled study.
- Association of Cardiac Troponin I With Disease Severity and Outcomes in Patients With Pulmonary Hypertension.
- Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices.
- Relationship of Right- to Left-Ventricular Filling Pressures in Advanced Heart Failure: Insights from the ESCAPE Trial.
- Is the inferior vena cava really superior?
- Health insurance as a requirement to undergo cardiac transplantation: a national survey of transplant program practices.
- Biomarkers of Chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
- The natural history of new-onset Heart failure with a severely depressed left ventricular ejection fraction: Implications for timing of implantable cardioverter-defibr...
- Left Atrial structure and function and clinical outcomes in the general population.
- Sirolimus use and incidence of Venous thromboembolism in cardiac transplant recipients.
- Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose Acute rejection in pediatric cardiac transplant recipie...
- Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device Thrombosis.
- The effects of rosiglitazone on Myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial.
- Relationship of right- and left-sided filling pressures in patients with advanced Heart failure: A 14-year multi-institutional analysis.
- Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up.
- Progression from Concentric Left Ventricular Hypertrophy and Normal Ejection Fraction to Left Ventricular Dysfunction.
- Mismatch of right- and left-sided filling pressures in chronic Heart failure.
- Risk scores versus natriuretic peptides for identifying prevalent stage B Heart failure.
- Cardiorespiratory fitness and classification of risk of cardiovascular Disease mortality.
- The progression of hypertensive Heart disease.
- Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.
- Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients.
- An automated model to identify Heart failure patients at risk for 30-day readmission or death using electronic medical record data.
- Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study.
- Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals.
- Clinical outcomes after cardiac transplantation in muscular dystrophy patients.
- A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas Heart study.
- The relationship of right- and left-sided filling pressures in patients with Heart failure and a preserved ejection fraction.
- Newer biomarkers in Heart failure.
- Pancreatic gout masquerading as pancreatic cancer in a Heart transplant candidate.
- Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced Heart failure: the BioImpedance CardioGraphy (BIG) substudy of t...
- Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.
- Racial differences in Heart failure.
- Clinical assessment of Heart failure: utility of symptoms, signs, and daily weights.
- Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
- Association of cystatin C with left ventricular structure and function: the Dallas Heart Study.
- Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).
- Relation of lack of knowledge about dietary sodium to hospital readmission in patients with Heart failure.
- The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study.
- Value of clinician assessment of hemodynamics in advanced Heart failure: the ESCAPE trial.
- Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in Heart failure.
- Utility of the Cylex assay in cardiac transplant recipients.
- Characteristics and outcomes in African American patients with decompensated Heart failure.
- Economic barriers in organ transplantation.
- Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: the Dallas Heart Study (DHS).
- High incidence of cytomegalovirus disease in D+/R- Heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis.
- Will the lessons from primary aldosteronism change the treatment of Hypertension and left ventricular hypertrophy?
- Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation.
- Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function.
- Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload.
- Left ventricular geometry: does shape matter?
- Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume.
- A risk score for predicting death in Chagas' Heart disease.
- Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of Heart failure follow?
- Low voltage on the electrocardiogram is a marker of disease severity and a risk factor for adverse outcomes in patients with Heart failure due to systolic dysfunction.
- Prevalence and determinants of troponin T elevation in the general population.
- Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study.
- High-sodium food choices by southern, urban African Americans with Heart failure.
- A Heartfelt story for the rich.
- Relation of Coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic pop...
- Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and Hypertension.
- Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
- Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic Heart failure (from the Studies of Left Ventricular Dysfuncti...
- Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation.
- The transition from hypertrophy to Failure: how certain are we?
- The impact of race on response to RAAS inhibition.
- Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study.
- Does load-induced ventricular hypertrophy progress to systolic Heart failure?
- Assessing prognosis in Heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
- Health insurance and cardiac transplantation: a call for reform.
- Influence of race on death and ischemic complications in patients with non-ST-elevation Acute coronary syndromes despite modern, protocol-guided treatment.
- Unexpected BNP levels in patients with advanced Heart failure: a tale of caution and promise.
- Beta-blocker therapy in patients with Heart failure in the urban setting: moving beyond clinical trials.
- Effects of diabetes mellitus and ischemic Heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic Heart failure: a retrospective...
- Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study.
- Left ventricular hypertrophy is more common in black than white Hypertensives: is this news?
- Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction.
- Racial response to angiotensin-converting enzyme therapy in systolic Heart failure.
- Therapy of Heart failure in African Americans: lessons from an urban public hospital.
- The prognostic value of the physical examination in patients with chronic Heart failure.
- Third heart sound and elevated jugular Venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunc...
- Hypertonic saline: a novel therapy for advanced Heart failure?
- Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic Heart failure in black and w...
- Comparison of impedance cardiography with invasive hemodynamic measurements in patients with Heart failure secondary to ischemic or nonischemic cardiomyopathy.
- Potential contributing factors to noncompliance with dietary sodium restriction in patients with Heart failure.
Schools
Washington University St Louis
University Tex Southwestern Dallas
Brigham and Women39s Hospital
Duke University Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- GEHA
- HealthFirst
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Scott & White Health Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Super Doctor
Education
-
Brigham and Women's Hospital -
Duke University Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
University of Texas Southwestern Medical Center
Drug Facts
| NPI NUMBER | 1285699009 | |
| NPPES Provider LastName | DRAZNER | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1676.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 1.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285699009 |
| Last Name Of The Provider | DRAZNER |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Eric J. Eichhorn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Harper, MD |
|
|
Dr. Alpesh A. Amin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon C. Reimold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Edupuganti, MD |
|
|
Dr. Shuaib Abdullah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tony S. Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wanpen Vongpatanasin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Aggarwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Rutherford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Chandrasekhara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hurst M. Hall III, MD
This Doctor is OpenDoctor Recommended.
|